Voyager 1 and 2 have traveled billions of miles over nearly half a century. NASA intends the Voyager program to continue its historic exploration for at least another few years. But after nearly half ...

J.P. Morgan on Monday reinstated coverage of Voyager Technologies (VOYG) with an Overweight rating, arguing that the aerospace and defense startup is positioned for faster-than-expected revenue growth ...

- Additional new data demonstrate VY-TAU01, Voyager’s lead antibody targeting pathological tau, was well-tolerated and demonstrated favorable pharmacokinetics in non-human primates (NHPs) - - Data to ...

Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - - Sharpened focus on ...

Single dose of TRACER AAV vector encoding anti-HER2 antibody reduced CNS tumor burden and extended survival across multiple mouse models of breast cancer brain metastasis Novel AAV5-derived capsid ...

- Voyager to receive up-front consideration of $175 million including a $39 million equity investment, up to $1.5 billion in potential development milestones, additional potential commercial ...

Crypto lender Voyager Digital's rewards program, a part of which was once the target of a state regulator investigation, has lost money almost every month since its inception, a new court filing shows ...

- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s ...

KINGSTON — Hudson River Maritime Museum (HRMM) invites parents to give their kids the experience of a lifetime this summer by signing them up for its new HRMM Voyager Program. Adventure meets learning ...

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...

CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today ...